From: One step forward, one step sideways? Expanding research capacity for neglected diseases
Type | Definition | Example | Barriers to therapy in developing countries |
---|---|---|---|
Type 1 | Diseases that are incident in both developed and developing countries with large numbers of vulnerable populations in both groups of countries | Diabetes | No market incentive to invest in interventions adapted to the resources and social and economic conditions of developing countries |
Type 2 | Diseases that are incident in both developed and developing countries but with a substantial proportion of the cases in developing countries | HIV | Type or strain of disease different in developed and developing countries |
Type 3 | Diseases that are overwhelmingly or exclusively incident in developing countries | Chagas disease | No market incentive to invest in research |